Literature DB >> 18428019

The assembly of apoB-containing lipoproteins: a structural biology point of view.

Leonard J Banaszak1, Wasantha K Ranatunga.   

Abstract

Atherosclerosis is a widespread disease caused by the deposition of lipids on arterial walls. Such lipid plaques in coronary arteries can be fatal. Although many factors related to diet, life-style, etc. contribute to the worsening of the ailment, the primary cause, the lipids in the circulatory system, come from a series of low-density lipoproteins. These lipoproteins are necessary for the transport of lipids to and from different organs. It would be valuable to medicine and the field of drug design if a more detailed understanding of the organization of lipid and protein in these molecules were available. Unfortunately because of heterogeneity in their size and lipid composition, all classes of the low-density serum lipoproteins appear to be not amenable to the most widely used method for obtaining detailed atomic data - X-ray crystallography. However there appears to be a recently identified homolog that is relatively homogeneous, and crystal structures have been obtained. Used as a molecular model, the homolog serves as a source of conformational information that might help to unravel the processes involved in the lipid loading of the low-density lipoproteins. The review attempts to give a brief summary of the structural biology of the serum low-density lipoproteins relative to the molecular model of lipovitellin.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18428019     DOI: 10.1080/07853890701813070

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  3 in total

1.  CREBH mediates metabolic inflammation to hepatic VLDL overproduction and hyperlipoproteinemia.

Authors:  Yongyan Song; Miaoyun Zhao; Xiao Cheng; Jing Shen; Rituraj Khound; Kezhong Zhang; Qiaozhu Su
Journal:  J Mol Med (Berl)       Date:  2017-04-28       Impact factor: 4.599

2.  The crystal structure of human microsomal triglyceride transfer protein.

Authors:  Ekaterina I Biterova; Michail N Isupov; Ronan M Keegan; Andrey A Lebedev; Anil A Sohail; Inam Liaqat; Heli I Alanen; Lloyd W Ruddock
Journal:  Proc Natl Acad Sci U S A       Date:  2019-08-08       Impact factor: 11.205

3.  LZP is required for hepatic triacylglycerol transportation through maintaining apolipoprotein B stability.

Authors:  Jiao-Xiang Wu; Kun-Yan He; Zhuang-Zhuang Zhang; Yu-Lan Qu; Xian-Bin Su; Yi Shi; Na Wang; Lan Wang; Ze-Guang Han
Journal:  PLoS Genet       Date:  2021-02-16       Impact factor: 5.917

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.